动脉样硬化的新目标:血管光滑肌肉细胞可塑性和巨细胞极性
Michael Hutton1, Madeleine Frazer1, Alexander Lin2
1Atherosclerosis and Vascular Remodeling Group, Heart Research Institute, Sydney, New South Wales, Australia.
Clinical therapeutics
|September 14, 2023
概括
动脉样硬化仍然是导致死亡的主要原因. 针对光滑肌细胞 (SMC) 和巨细胞中的血管细胞可塑性,为减少心血管事件提供了新的治疗途径.
科学领域:
- 心血管研究研究心血管研究
- 细胞生物学 细胞生物学
- 翻译医学是一种翻译医学.
背景情况:
- 动脉样硬化是全球过早死亡的主要原因,尽管治疗方面取得了进展.
- 创新疗法对于进一步降低动脉样硬化相关死亡率至关重要.
- 斑块内的血管细胞表型在疾病进展中起着关键作用.
研究的目的:
- 探索血管细胞可塑性作为动脉样硬化治疗点.
- 审查转录学和命运映射研究如何阐明细胞表型在斑块稳定性的研究.
- 基于血管细胞异质性的新型治疗策略.
主要方法:
- 一个关于近期文学的叙事评论.
- 在电子数据库 (谷歌学者,PubMed) 中进行的搜索.
- 包括来自参考清单和作者数据库的研究.
主要成果:
- SMCs和巨细胞表现出不同的表型,影响斑块稳定性和疾病负担.
- 炎症环境驱动SMC表型切换和巨细胞两极分化.
- 像他类药物这样的现有治疗方法对巨细胞两极分化产生了影响,这表明有针对性的方法.
结论:
- 血管细胞的表型异质性是未来减少心血管事件的关键领域.
- SMC可塑性和巨细胞极性为开发新的动脉样硬化治疗方法提供了坚实的基础.
- 准这些细胞表型有可能改善患者的治疗结果,并减少不良事件.
更多相关视频
06:43Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
Published on: December 7, 2013
13.8K
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
3.7K
相关概念视频
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Inflammation
53.8K
Overview
53.8K
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
